These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 10590323)

  • 1. Totally synthetic lipid-containing polyoxime peptide constructs are potent immunogens.
    Zeng W; Jackson DC; Murray J; Rose K; Brown LE
    Vaccine; 2000 Jan; 18(11-12):1031-9. PubMed ID: 10590323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasmodium falciparum polyoximes: highly immunogenic synthetic vaccines constructed by chemoselective ligation of repeat B-cell epitopes and a universal T-cell epitope of CS protein.
    Nardin EH; Calvo-Calle JM; Oliveira GA; Clavijo P; Nussenzweig R; Simon R; Zeng W; Rose K
    Vaccine; 1998 Apr; 16(6):590-600. PubMed ID: 9569470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A synthetic peptide-based polyoxime vaccine construct of high purity and activity.
    Rose K; Zeng W; Brown LE; Jackson DC
    Mol Immunol; 1995 Oct; 32(14-15):1031-7. PubMed ID: 8544852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dependence of the murine antibody response to an anti-CDR2 VH peptide on immunogen formulation.
    Kanda P; Fritz DA; Gage DA; Shuler KR
    Mol Immunol; 1995 Dec; 32(17-18):1319-28. PubMed ID: 8643101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of various adjuvants on antibody synthesis following immunization with an hapten.
    Kellner J; Erhard M; Schranner I; Lösch U
    Biol Chem Hoppe Seyler; 1992 Jan; 373(1):51-5. PubMed ID: 1536694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intranasal vaccination of recombinant H5N1 HA1 proteins fused with foldon and Fc induces strong mucosal immune responses with neutralizing activity: Implication for developing novel mucosal influenza vaccines.
    Yu F; Li Y; Guo Y; Wang L; Yang J; Zhao G; Zhou Y; Du L; Jiang S
    Hum Vaccin Immunother; 2015; 11(12):2831-8. PubMed ID: 26260706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mucosal immunization with recombinant influenza hemagglutinin protein and poly gamma-glutamate/chitosan nanoparticles induces protection against highly pathogenic influenza A virus.
    Moon HJ; Lee JS; Talactac MR; Chowdhury MY; Kim JH; Park ME; Choi YK; Sung MH; Kim CJ
    Vet Microbiol; 2012 Dec; 160(3-4):277-89. PubMed ID: 22763171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intranasal c-di-GMP-adjuvanted plant-derived H5 influenza vaccine induces multifunctional Th1 CD4+ cells and strong mucosal and systemic antibody responses in mice.
    Madhun AS; Haaheim LR; Nøstbakken JK; Ebensen T; Chichester J; Yusibov V; Guzman CA; Cox RJ
    Vaccine; 2011 Jul; 29(31):4973-82. PubMed ID: 21600260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective effect of nasal immunization of influenza virus hemagglutinin with recombinant cholera toxin B subunit as a mucosal adjuvant in mice.
    Isaka M; Zhao Y; Nobusawa E; Nakajima S; Nakajima K; Yasuda Y; Matsui H; Hasegawa T; Maeyama J; Morokuma K; Ohkuma K; Tochikubo K
    Microbiol Immunol; 2008 Feb; 52(2):55-63. PubMed ID: 18380802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A totally synthetic polyoxime malaria vaccine containing Plasmodium falciparum B cell and universal T cell epitopes elicits immune responses in volunteers of diverse HLA types.
    Nardin EH; Calvo-Calle JM; Oliveira GA; Nussenzweig RS; Schneider M; Tiercy JM; Loutan L; Hochstrasser D; Rose K
    J Immunol; 2001 Jan; 166(1):481-9. PubMed ID: 11123327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complete protection of mice from respiratory syncytial virus infection following mucosal delivery of synthetic peptide vaccines.
    Bastien N; Trudel M; Simard C
    Vaccine; 1999 Feb; 17(7-8):832-6. PubMed ID: 10067688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of recombinant flagellin in oil-in-water emulsions enhances hemagglutinin-specific mucosal IgA production and IL-17 secreting T cells against H5N1 avian influenza virus infection.
    Lai CH; Tang N; Jan JT; Huang MH; Lu CY; Chiang BL; Huang LM; Wu SC
    Vaccine; 2015 Aug; 33(35):4321-9. PubMed ID: 25858857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in antibody responses of mice to intranasal or intraperitoneal immunization with influenza A virus and vaccination with subunit influenza vaccine.
    Fislová T; Sládková T; Gocník M; Mucha V; Varecková E; Kostolanský F
    Acta Virol; 2005; 49(4):243-50. PubMed ID: 16402681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthetic Toll-Like Receptor 4 (TLR4) and TLR7 Ligands Work Additively via MyD88 To Induce Protective Antiviral Immunity in Mice.
    Goff PH; Hayashi T; He W; Yao S; Cottam HB; Tan GS; Crain B; Krammer F; Messer K; Pu M; Carson DA; Palese P; Corr M
    J Virol; 2017 Oct; 91(19):. PubMed ID: 28724768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modified pulmonary surfactant is a potent adjuvant that stimulates the mucosal IgA production in response to the influenza virus antigen.
    Mizuno D; Ide-Kurihara M; Ichinomiya T; Kubo I; Kido H
    J Immunol; 2006 Jan; 176(2):1122-30. PubMed ID: 16394001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intranasal immunization with SIV virus-like particles (VLPs) elicits systemic and mucosal immunity.
    Yao Q; Vuong V; Li M; Compans RW
    Vaccine; 2002 Jun; 20(19-20):2537-45. PubMed ID: 12057610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and characterization of chitosan coated poly-(ɛ-caprolactone) nanoparticulate system for effective immunization against influenza.
    Gupta NK; Tomar P; Sharma V; Dixit VK
    Vaccine; 2011 Nov; 29(48):9026-37. PubMed ID: 21939718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mucosal immunity to HIV-1: systemic and vaginal antibody responses after intranasal immunization with the HIV-1 C4/V3 peptide T1SP10 MN(A).
    Staats HF; Nichols WG; Palker TJ
    J Immunol; 1996 Jul; 157(1):462-72. PubMed ID: 8683152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 1H NMR structural study of free and template-linked antigenic peptide representing the C-terminal region of the heavy chain of influenza virus hemagglutinin.
    Wilce JA; Zeng W; Rose K; Craik DJ; Jackson DC
    Biomed Pept Proteins Nucleic Acids; 1996; 2(2):51-8. PubMed ID: 9346827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bacterium-like particles supplemented with inactivated influenza antigen induce cross-protective influenza-specific antibody responses through intranasal administration.
    de Haan A; Haijema BJ; Voorn P; Meijerhof T; van Roosmalen ML; Leenhouts K
    Vaccine; 2012 Jul; 30(32):4884-91. PubMed ID: 22537989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.